Varonis Systems Inc.
Congress has disclosed 0 buys and 1 sell of VRNS (Varonis Systems Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
1 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Donna Shalala | House | SELL | Self | 2019-06-24 | 6 days | — | $1K–$15K | 75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in VRNS — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in VRNS, 0 coincided with corporate insiders moving the same way within 60 days, and 0 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-02-09 | Bass David | Other | BUY | $70K | ↗ EDGAR |
| 2026-02-09 | Faitelson Yakov | C-suite | BUY | $599K | ↗ EDGAR |
| 2026-02-06 | Kess Avrohom J. | Director | BUY | $397K | ↗ EDGAR |
| 2026-02-06 | GAVIN JOHN J JR | Director | BUY | $113K | ↗ EDGAR |
| 2025-08-29 | Melamed Guy | C-suite | SELL 10b5-1 | $89K | ↗ EDGAR |
| 2025-08-28 | Melamed Guy | C-suite | SELL 10b5-1 | $232K | ↗ EDGAR |
| 2025-08-22 | Melamed Guy | C-suite | SELL 10b5-1 | $619K | ↗ EDGAR |
| 2025-08-13 | Melamed Guy | C-suite | SELL 10b5-1 | $2.5M | ↗ EDGAR |
| 2025-08-01 | VAN DEN BOSCH FRED | Director | SELL 10b5-1 | $165K | ↗ EDGAR |
| 2025-08-01 | Melamed Guy | C-suite | SELL 10b5-1 | $2.9M | ↗ EDGAR |
| 2025-06-04 | VAN DEN BOSCH FRED | Director | SELL 10b5-1 | $300K | ↗ EDGAR |
| 2024-11-13 | Melamed Guy | C-suite | SELL | $3.6M | ↗ EDGAR |
| 2024-11-13 | Melamed Guy | C-suite | SELL | $1.3M | ↗ EDGAR |
| 2024-10-15 | O'Boyle James | Other | SELL 10b5-1 | $3.0M | ↗ EDGAR |
| 2024-08-06 | O'Boyle James | Other | SELL 10b5-1 | $2.1M | ↗ EDGAR |
| 2024-08-06 | O'Boyle James | Other | SELL 10b5-1 | $1.7M | ↗ EDGAR |
| 2024-05-10 | Faitelson Yakov | C-suite | SELL | $2.1M | ↗ EDGAR |
| 2024-05-09 | Faitelson Yakov | C-suite | SELL | $12.9M | ↗ EDGAR |
| 2024-02-29 | Iohan Gili | Director | SELL | $986K | ↗ EDGAR |
| 2024-02-12 | Kess Avrohom J. | Director | BUY | $12K | ↗ EDGAR |
| 2024-02-09 | Segev Ofer | Director | SELL | $261K | ↗ EDGAR |
| 2024-02-09 | Bass David | Other | SELL | $669K | ↗ EDGAR |
| 2024-02-09 | Bass David | Other | SELL | $36K | ↗ EDGAR |
| 2024-02-08 | Melamed Guy | C-suite | SELL | $7.5M | ↗ EDGAR |
| 2024-02-08 | Melamed Guy | C-suite | SELL | $686K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-02-09 | Bass David Other | BUY | $70K |
| ◆ insider | 2026-02-09 | Faitelson Yakov C-suite | BUY | $599K |
| ◆ insider | 2026-02-06 | Kess Avrohom J. Director | BUY | $397K |
| ◆ insider | 2026-02-06 | GAVIN JOHN J JR Director | BUY | $113K |
| ◆ insider | 2025-08-29 | Melamed Guy C-suite 10b5-1 | SELL | $89K |
| ◆ insider | 2025-08-28 | Melamed Guy C-suite 10b5-1 | SELL | $232K |
| ◆ insider | 2025-08-22 | Melamed Guy C-suite 10b5-1 | SELL | $619K |
| ◆ insider | 2025-08-13 | Melamed Guy C-suite 10b5-1 | SELL | $2.5M |
| ◆ insider | 2025-08-01 | VAN DEN BOSCH FRED Director 10b5-1 | SELL | $165K |
| ◆ insider | 2025-08-01 | Melamed Guy C-suite 10b5-1 | SELL | $2.9M |
| ◆ insider | 2025-06-04 | VAN DEN BOSCH FRED Director 10b5-1 | SELL | $300K |
| ◆ insider | 2024-11-13 | Melamed Guy C-suite | SELL | $3.6M |
| ◆ insider | 2024-11-13 | Melamed Guy C-suite | SELL | $1.3M |
| ◆ insider | 2024-10-15 | O'Boyle James Other 10b5-1 | SELL | $3.0M |
| ◆ insider | 2024-08-06 | O'Boyle James Other 10b5-1 | SELL | $2.1M |
| ◆ insider | 2024-08-06 | O'Boyle James Other 10b5-1 | SELL | $1.7M |
| ◆ insider | 2024-05-10 | Faitelson Yakov C-suite | SELL | $2.1M |
| ◆ insider | 2024-05-09 | Faitelson Yakov C-suite | SELL | $12.9M |
| ◆ insider | 2024-02-29 | Iohan Gili Director | SELL | $986K |
| ◆ insider | 2024-02-12 | Kess Avrohom J. Director | BUY | $12K |
| ◆ insider | 2024-02-09 | Segev Ofer Director | SELL | $261K |
| ◆ insider | 2024-02-09 | Bass David Other | SELL | $669K |
| ◆ insider | 2024-02-09 | Bass David Other | SELL | $36K |
| ◆ insider | 2024-02-08 | Melamed Guy C-suite | SELL | $7.5M |
FAQ Common questions
How much has Congress traded VRNS?
0 disclosed buys and 1 sells of VRNS (Varonis Systems Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade VRNS?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.